Anemik Hastaya Yaklaşım
Özet
Bu tıbbi metin, iç hastalıkları pratiğinde sıkça karşılaşılan anemiye tanısal yaklaşımı, eritrosit indekslerini (MCV, MCH, RDW), retikülosit sayımını ve aneminin etiyolojik sınıflandırmasını kapsamlı bir şekilde ele almaktadır. Demir eksikliği anemisi dünyada en sık görülen tür olup diyet yetersizliği veya kan kaybı kaynaklıdır; tedavisinde oral veya parenteral demir preparatları kullanılır. Genetik bir hemoglobin sentezi bozukluğu olan beta talasemi ise majör, intermedia ve minör olmak üzere klinik formlara ayrılır. Kronik hastalık anemisi, enflamasyon ve enfeksiyon süreçlerinde sitokin disregülasyonu ile gelişen ikinci en sık anemi türüdür. Eritrositlerin erken yıkımıyla karakterize hemolitik anemiler, genetik veya otoimmün nedenlerle ortaya çıkar ve immün kaynaklı vakalarda ilk seçenek olarak kortikosteroid tedavisi uygulanır. Son olarak, MCV yüksekliğiyle seyreden makrositer anemiler arasında hipotiroidi, yetersiz beslenme, emilim bozuklukları veya ilaç kullanımına bağlı olarak gelişen B12 vitamini ve folat eksiklikleri yer alır. Bu tür anemilerin yönetiminde parenteral veya oral vitamin replasman protokolleri uygulanarak laboratuvar yanıtları retikülosit ve hemoglobin takibiyle izlenir.
This medical text comprehensively addresses the diagnostic approach to anemia in internal medicine practice, covering erythrocyte indices (MCV, MCH, RDW), reticulocyte counts, and etiological classifications. Iron deficiency anemia is the most prevalent type worldwide, arising from dietary insufficiency or blood loss, and is managed with oral or parenteral iron preparations. Beta thalassemia, a genetic hemoglobin synthesis disorder, is divided into major, intermedia, and minor clinical forms. Anemia of chronic disease is the second most common type, developing via cytokine dysregulation during inflammation and infectious processes. Hemolytic anemias, characterized by premature erythrocyte destruction, stem from genetic or autoimmune causes, with corticosteroids serving as the primary treatment line for immune-mediated cases. Finally, macrocytic anemias presenting with elevated MCV include hypothyroidism and vitamin B12 or folate deficiencies caused by malnutrition, malabsorption, or medication usage. The management of these anemias utilizes parenteral or oral vitamin replacement protocols, monitoring laboratory responses via reticulocyte and hemoglobin follow-ups.
Referanslar
Adeli K, Higgins V, Nieuwesteeg M, et al. Biochemical marker reference values across pediatric, adult, and geriatric ages: establishment of robust pediatric and adult reference intervals on the basis of the Canadian Health Measures Survey. Clin Chem. 2015 Aug;61(8):1049-62. doi: 10.1373/clinchem.2015.240515.
Van den Bossche J, Devreese K, Malfait R, et al. Reference intervals for a complete blood count determined on different automated haematology analysers: Abx Pentra 120 Retic, Coulter Gen-S, Sysmex SE 9500, Abbott Cell Dyn 4000 and Bayer Advia 120. Clin Chem Lab Med. 2002 Jan;40(1):69-73. doi: 10.1515/CCLM.2002.014.
Means RT. Iron Deficiency and Iron Deficiency Anemia: Implications and Impact in Pregnancy, Fetal Development, and Early Childhood Parameters. Nutrients. 2020 Feb 11;12(2):447. doi: 10.3390/nu12020447.
Erslev AJ. Reticulocyte enumeration. In: Williams' Hematology, 5th ed, Beutler E, Lichtman MA, Coller BS, et al. (Eds), McGraw-Hill, New York 1995. p.L28.
Valeri CR, Dennis RC, Ragno G, et al. Limitations of the hematocrit level to assess the need for red blood cell transfusion in hypovolemic anemic patients. Transfusion. 2006 Mar;46(3):365-71. doi: 10.1111/j.1537-2995.2006.00730.x.
Price EA, Mehra R, Holmes TH, et al. Anemia in older persons: etiology and evaluation. Blood Cells Mol Dis. 2011 Feb 15;46(2):159-65. doi: 10.1016/j.bcmd.2010.11.004.
Lopez A, Cacoub P, Macdougall IC, et al. Iron deficiency anaemia. Lancet. 2016 Feb 27;387(10021):907-16. doi: 10.1016/S0140-6736(15)60865-0.
Tolkien Z, Stecher L, Mander AP, et al. Ferrous sulfate supplementation causes significant gastrointestinal side-effects in adults: a systematic review and meta-analysis. PLoS One. 2015 Feb 20;10(2):e0117383. doi: 10.1371/journal.pone.0117383.
Auerbach M, Deloughery T. Single-dose intravenous iron for iron deficiency: a new paradigm. Hematology Am Soc Hematol Educ Program. 2016 Dec 2;2016(1):57-66. doi: 10.1182/asheducation-2016.1.57.
Olivieri NF, Brittenham GM, Matsui D, et al. Iron-chelation therapy with oral deferiprone in patients with thalassemia major. N Engl J Med. 1995 Apr 6;332(14):918-22. doi: 10.1056/NEJM199504063321404.
Musallam KM, Rivella S, Vichinsky E, et al. Non-transfusion-dependent thalassemias. Haematologica. 2013 Jun;98(6):833-44. doi: 10.3324/haematol.2012.066845.
Premawardhena A, Arambepola M, Katugaha N, et al. Is the beta thalassaemia trait of clinical importance? Br J Haematol. 2008 May;141(3):407-10. doi: 10.1111/j.1365-2141.2008.07071.x.
Armitage AE, Eddowes LA, Gileadi U, et al. Hepcidin regulation by innate immune and infectious stimuli. Blood. 2011 Oct 13;118(15):4129-39. doi: 10.1182/blood-2011-04-351957.
Weiss G, Ganz T, Goodnough LT. Anemia of inflammation. Blood. 2019 Jan 3;133(1):40-50. doi: 10.1182/blood-2018-06-856500.
Weiss G, Goodnough LT. Anemia of chronic disease. N Engl J Med. 2005 Mar 10;352(10):1011-23. doi: 10.1056/NEJMra041809.
Lechner K, Jäger U. How I treat autoimmune hemolytic anemias in adults. Blood. 2010 Sep 16;116(11):1831-8. doi: 10.1182/blood-2010-03-259325. Epub 2010 Jun 14. PMID: 20548093.
Horton L, Coburn RJ, England JM, Himsworth RL. The haematology of hypothyroidism. Q J Med. 1976 Jan;45(177):101-23.
Green R. Vitamin B12 deficiency from the perspective of a practicing hematologist. Blood. 2017 May 11;129(19):2603-2611. doi: 10.1182/blood-2016-10-569186
Devalia V, Hamilton MS, Molloy AM; British Committee for Standards in Haematology. Guidelines for the diagnosis and treatment of cobalamin and folate disorders. Br J Haematol. 2014 Aug;166(4):496-513. doi: 10.1111/bjh.12959.
Eussen SJ, de Groot LC, Clarke R, et al. Oral cyanocobalamin supplementation in older people with vitamin B12 deficiency: a dose-finding trial. Arch Intern Med. 2005 May 23;165(10):1167-72. doi: 10.1001/archinte.165.10.1167.
Devalia V, Hamilton MS, Molloy AM; British Committee for Standards in Haematology. Guidelines for the diagnosis and treatment of cobalamin and folate disorders. Br J Haematol. 2014 Aug;166(4):496-513. doi: 10.1111/bjh.12959
